Cadila Healthcare to consider unaudited financial results

16 Jan 2013 Evaluate

Cadila Healthcare has informed that a meeting of the board of directors of the company will be held on February 08, 2013, to consider unaudited financial results for the quarter/nine months ended on December 31, 2012.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

884.85 8.75 (1.00%)
22-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1634.40
Dr. Reddys Lab 1217.15
Cipla 1371.55
Zydus Lifesciences 884.85
Lupin 2165.05
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×